Global Pediatric Brain Tumor Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Gliomas, Mixed Neuronal-Glial Tumors, Embryonal Tumors, Choroid Plexus Papilloma/Carcinoma, Tumors Arising From Non-Neuroepithelial Tissue, Meningeal Tumors, and Others.

By Diagnosis;

Physical Exam, Imaging Tests, Brain or Spinal Cord Tumor Biopsy, Lumbar Puncture (Spinal Tap), Blood and Urine Tests, and Others.

By Treatment;

Surgery, Therapies, and Others.

By End User;

Hospitals and Clinics, Medical Research Centers, Academic Institutes, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn898679670 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Pediatric Brain Tumor Market (USD Million), 2021 - 2031

In the year 2024, the Global Pediatric Brain Tumor Market was valued at USD 1,505.66 million. The size of this market is expected to increase to USD 1,941.68 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 3.7%.

The Global Pediatric Brain Tumor Market represents a critical frontier in pediatric oncology, where scientific advancements, clinical innovation, and patient-centric care converge to address the unique challenges posed by childhood brain tumors. Pediatric brain tumors, though relatively rare compared to adult counterparts, present complex clinical scenarios characterized by diverse histological subtypes, variable treatment responses, and long-term sequelae. This introduction aims to provide a comprehensive overview of the Global Pediatric Brain Tumor Market, shedding light on key trends, challenges, and opportunities shaping the landscape of pediatric neuro-oncology.

Childhood brain tumors constitute a heterogeneous group of neoplasms arising within the central nervous system, encompassing a wide spectrum of histologies, including gliomas, medulloblastomas, ependymomas, and embryonal tumors. Despite significant progress in diagnosis and treatment over the years, pediatric brain tumors remain a leading cause of cancer-related morbidity and mortality in children, highlighting the urgent need for continued research and therapeutic innovation.

The Global Pediatric Brain Tumor Market is characterized by a multifaceted ecosystem of stakeholders, including pharmaceutical companies, biotechnology firms, academic institutions, research organizations, healthcare providers, advocacy groups, and regulatory agencies. These stakeholders collaborate across various domains, from basic research and drug development to clinical trials and patient care, to advance the understanding and management of pediatric brain tumors.

In recent years, the Global Pediatric Brain Tumor Market has witnessed notable advancements in several key areas. These include molecular profiling and precision medicine initiatives aimed at unraveling the genomic landscape of pediatric brain tumors and identifying targeted therapeutic vulnerabilities. Moreover, innovative treatment modalities, such as immunotherapy, targeted therapy, and adoptive cell therapy, have emerged as promising avenues for improving treatment outcomes and minimizing treatment-related toxicities in children with brain tumors.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Diagnosis
    3. Market Snapshot, By Treatment
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Pediatric Brain Tumor Market Trends
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Precision Medicine
        2. Molecular Profiling
        3. Targeted Therapy
        4. Immunotherapy
      2. Restraints
        1. Limited Funding
        2. Treatment Toxicities
        3. Tumor Heterogeneity
        4. Access to Innovative Therapies
      3. Opportunities
        1. Precision Oncology
        2. Biomarker Discovery
        3. Immunotherapy Advancements
        4. Targeted Therapies Development
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Global Pediatric Brain Tumor Market, By Product Type, 2021 - 2031(USD Million)
      1. Gliomas
      2. Mixed Neuronal-Glial Tumors
      3. Embryonal Tumors
      4. Choroid Plexus Papilloma/Carcinoma
      5. Tumors Arising From Non-Neuroepithelial Tissue
      6. Meningeal Tumors
      7. Others
    2. Global Pediatric Brain Tumor Market, By Diagnosis, 2021 - 2031 (USD Million)
      1. Physical Exam
      2. Imaging Tests
      3. Brain Or Spinal Cord Tumor Biopsy
      4. Lumbar Puncture (Spinal Tap)
      5. Blood And Urine Tests
      6. Others
    3. Global Pediatric Brain Tumor Market, By Treatment, 2021 - 2031 (USD Million)
      1. Surgery
      2. Therapies
      3. Others
    4. Global Pediatric Brain Tumor Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals and Clinics
      2. Medical Research Centers
      3. Academic Institutes
      4. Others
    5. Global Pediatric Brain Tumor Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Abbott
      2. AbbVie Inc
      3. Akorn Inc
      4. Agios Inc
  7. Analyst Views
  8. Future Outlook of the Market